CoChat
Sign Up
Cited by 216Diabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Health and Risk FactorsHealthcare Systems and Public Health

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm

Gorter, Petra M, Olijhoek, Jobien K, van der Graaf, Yolanda, Algra, Ale, Rabelink, Ton J, Visseren, Frank L.J·2004·Atherosclerosis
DOI 10.1016/j.atherosclerosis.2003.12.033
Open this paper in CoChat — free account

Abstract

Metabolic syndrome patients are at increased risk for developing cardiovascular morbidity and mortality. The increasing prevalence of the metabolic syndrome in various asymptomatic populations has been well documented, however, limited information is available about the prevalence in manifest atherosclerotic vascular disease patients. The aim of this study is to determine the overall and gender-specific prevalence of the metabolic syndrome and its components in these patients. This cross-sectional survey of 1117 patients, aged 18-80 years, mean age 60+/-10 years, comprised patients with coronary heart disease (n=527), cerebrovascular disease (n=258), peripheral arterial disease (n=232) or abdominal aortic aneurysm (n=100). Metabolic syndrome was defined by Adult Treatment Panel III. The prevalence of the metabolic syndrome in the study population was 46%: 58% in PAD patients, 41% in CHD patients, 43% in CVD patients and 47% in AAA patients. Overall, women had a higher prevalence than men (56% versus 43%). Age did not influence the metabolic syndrome prevalence; crude odds ratios (crude OR) 1.00 (95% CI: 0.99-1.02). Our results demonstrate a high prevalence of the metabolic syndrome in patients with manifest atherosclerotic vascular disease. Screening for metabolic syndrome in patients with high risk for new vascular incidents may identify patients with even higher vascular risk and may direct anti-atherosclerotic treatment in order to prevent new vascular incidents in the same or another vascular bed.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.atherosclerosis.2003.12.033

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 18 references

Cited by

Sorted by citations

Items 201–216 of 216

Related

See all

Metadata

Authors
Gorter, P. M., Olijhoek, J. K., van der Graaf, Y., Algra, A., Rabelink, T. J., & Visseren, F. L. J.
Affiliations
University Medical Center Utrecht (NL)
Corresponding author
Olijhoek, Jobien K
ORCID
Venue
Atherosclerosis
Publisher
Elsevier BV
Published
2004-04
Volume
173
Issue
2
Pages
361-367
ISSN
0021-9150 (ISSN-L)
DOI
10.1016/j.atherosclerosis.2003.12.033
OpenAlex
W2020922372
Cited by
216
References
18
Citations by year
2026: 2 · 2025: 2 · 2024: 3 · 2023: 4 · 2022: 6 · 2021: 6 · 2020: 4 · 2019: 4 · 2018: 6 · 2017: 5 · 2016: 11 · 2015: 15 · 2014: 12 · 2013: 10 · 2012: 13
FWCI
12.28
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Atherosclerosis (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
  • Health Sciences › Medicine › Epidemiology › Healthcare Systems and Public Health
Keywords
metabolic syndrome, prevalence, coronary artery disease, cerebrovascular disease, peripheral arterial disease, abdominal aortic aneurysm, atherosclerosis, sex differences, metabolic syndrome screening, cardiovascular risk
MeSH terms
Adolescent, Adult, Aged, Aged, 80 and over, Arterial Occlusive Diseases, Cerebrovascular Disorders, Coronary Disease, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Netherlands, Cohort Studies, Comorbidity, Prevalence, Multivariate Analysis, Logistic Models, Survival Analysis, Peripheral Vascular Diseases, Aortic Aneurysm, Abdominal, Age Distribution, Sex Distribution, Risk Assessment, Metabolic Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review